Veritas In Silico Inc. (TYO:130A)

Japan flag Japan · Delayed Price · Currency is JPY
656.00
+7.00 (1.08%)
At close: May 16, 2025, 3:30 PM JST
-41.95%
Market Cap 4.26B
Revenue (ttm) 186.60M
Net Income (ttm) -228.62M
Shares Out 6.49M
EPS (ttm) -35.24
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 19,600
Average Volume 50,860
Open 650.00
Previous Close 649.00
Day's Range 650.00 - 670.00
52-Week Range 591.00 - 1,348.00
Beta n/a
RSI 41.87
Earnings Date May 9, 2025

About Veritas In Silico

Veritas In Silico Inc. engages in the business of small molecule drug discovery and nucleic acid drug discovery targeting mRNA. It has strategic partnership with Liverpool ChiroChem for the mRNA-targeted drug discovery and development. The company was incorporated in 2016 and is based in Shinagawa, Japan. [Read more]

Industry Surgical and Medical Instruments and Apparatus
Founded 2016
Country Japan
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 130A
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.